Literature DB >> 25627205

Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.

Raymond S W Tsang1, Linda Hoang2, Gregory Tyrrell3, Greg Horsman4, John Wylie5, Frances B Jamieson6, Brigitte Lefebvre7, Muhamed-Kheir Taha8.   

Abstract

We previously reported a shift in the electrophoretic type (ET) of invasive MenC in Canada from predominantly ET-15 to ET-37 in the post-MenC conjugate vaccine period. This study sought to confirm this trend by examining all culture-confirmed invasive MenC case isolates in Canada in the period from 1 January 2009 to 31 December 2013. Of the 50 MenC isolates, 18 belonged to ET-15, 28 belonged to ET-37 (but not ET-15), and four belonged to other clonal types. Analysis of the serotype and serosubtype antigens, porA and fetA gene sequences provided data to show that invasive MenC belonging to ET-15 and ET-37 were two very different subpopulations within the ST-11 clonal complex. Sequence analysis of the fHbp genes suggested that 12 different types of factor H-binding protein were found among the ET-15 isolates while 86 % of ET-37 isolates were found to have fHbp genes predicted to encode peptide 22. The nadA gene in 12 MenC isolates was disrupted due to IS1301 insertion and 11 of these 12 isolates belonged to ET-15. Ten per cent of the invasive MenC were found to have a frame-shift mutation in their fHbp genes that predicted no fHbp produced. Significant diversity and frame-shift mutations of fHbp genes were found in invasive MenC strains in Canada. Copyright belongs to the Public Health Agency of Canada.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627205     DOI: 10.1099/jmm.0.000006-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.

Authors:  Dennis K S Law; Brigitte Lefebvre; Rodica Gilca; Saul Deng; Jianwei Zhou; Philippe De Wals; Raymond S W Tsang
Journal:  BMC Microbiol       Date:  2015-07-25       Impact factor: 3.605

2.  Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?

Authors:  Jay Lucidarme; Aiswarya Lekshmi; Sydel R Parikh; James E Bray; Dorothea M Hill; Holly B Bratcher; Steve J Gray; Anthony D Carr; Keith A Jolley; Jamie Findlow; Helen Campbell; Shamez N Ladhani; Mary E Ramsay; Martin C J Maiden; Ray Borrow
Journal:  J Infect       Date:  2017-06-01       Impact factor: 6.072

3.  Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).

Authors:  Raymond Sw Tsang; Dennis Ks Law; Rita R Gad; Tim Mailman; Gregory German; Robert Needle
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.